PA

sponsor

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Evans JMM et al. - The results suggest that metformin use may be associated with a reduced risk of cancer. A randomized trial is needed to assess whether metformin is protective in a population at high risk for cancer.


Today in Endocrinology...keeping you current

Nutritional supplements and serum lipids: Does anything work
Current Atherosclerosis Reports, 11/16/09

Carbohydrate-restricted diets for obesity and related diseases: An update
Current Atherosclerosis Reports, 11/17/09

Systematic Review: Comparative Effectiveness and Harms of Combination Therapy and Monotherapy for Dyslipidemia
Annals of Internal Medicine, 11/03/09